PATENT DUCTUS ARTERIOSUS DEVICE CLOSURE IN GROWN UP PATIENTS

Abstract

Background & Aims: Transcatheter Patent ductus arteriosus (PDA) device closure is considered as safe and first line of treatment in patients who are technically suitable for procedure. This paper is sharing of our experience of percutaneous device closure of PDAs in grown up patients (more than eighteen years of age) with review of efficacy and immediate complications encountered during PDA device closure at our setup.

Study Design: Case series, retrospective study.

Place and Duration of Study: Department of Paediatric cardiology, Armed Forces Institute of Cardiology and National Institute of Heart Diseases (AFIC-NIHD), Rawalpindi from June 2016 to Dec 2017.

Materials and methods: Consecutive twenty five patients (age more than eighteen years), who underwent attempted PDA device closure was included in the study.

Results: Total 25 patients (15 females & 10 males) were attempted PDA device closure with mean age of 29 years. In all cases PDA was successfully occluded with appropriate size devices and the mean diameter of PDA was 07 mm. Mean procedural & fluoroscopy times were 41 and 11.6 minutes respectively. There was no mortality, device embolization or residual leak in the study population.

Conclusion: Transcatheter device occlusion of PDA by various Occluder devices is safe and effective therapeutic option with high success rate and little morbidity in the hands of skilled operators.